Suppr超能文献

Management of leprosy patients in the era of COVID-19.

作者信息

Abdelmaksoud Ayman, Gupta Sunil Kumar

机构信息

Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.

Department of Dermatology, Venereology and Leprosy, AIIMS, Gorakhpur, India.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13631. doi: 10.1111/dth.13631. Epub 2020 Jun 24.

Abstract
摘要

相似文献

1
Management of leprosy patients in the era of COVID-19.
Dermatol Ther. 2020 Jul;33(4):e13631. doi: 10.1111/dth.13631. Epub 2020 Jun 24.
2
Will cases of leprosy reaction increase with COVID-19 infection?
PLoS Negl Trop Dis. 2020 Jul 17;14(7):e0008460. doi: 10.1371/journal.pntd.0008460. eCollection 2020 Jul.
3
Circulating endothelial cells in COVID-19.
Am J Hematol. 2020 Aug;95(8):E187-E188. doi: 10.1002/ajh.25881. Epub 2020 Jun 20.
4
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01634-2020. Print 2020 Jul.
5
Thoracic Anesthesia in the Coronavirus Disease 2019 (COVID-19) Era.
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2328-2330. doi: 10.1053/j.jvca.2020.05.008. Epub 2020 May 13.
7
Endothelial cells orchestrate COVID-19 coagulopathy.
Lancet Haematol. 2020 Aug;7(8):e553-e555. doi: 10.1016/S2352-3026(20)30215-5. Epub 2020 Jun 30.
8
Nursing workload in the COVID-19 era.
Intensive Crit Care Nurs. 2020 Dec;61:102929. doi: 10.1016/j.iccn.2020.102929. Epub 2020 Aug 11.
9
Specimens Received as a Critical Indicator for Blood Bank Preparedness in the SARS-CoV-2 Era.
Am J Clin Pathol. 2020 Sep 8;154(4):571-572. doi: 10.1093/ajcp/aqaa129.
10
[Recognition of critical coronavirus disease 2019: from the injury of alveolar epithelial cells to vascular endothelial cells].
Zhonghua Nei Ke Za Zhi. 2020 Sep 1;59(9):660-661. doi: 10.3760/cma.j.cn112138-20200323-00283.

引用本文的文献

1
Impact of the coronavirus disease 2019 on the diagnoses of Hansen's disease in Brazil.
Rev Soc Bras Med Trop. 2021 Jul 23;54:e02512021. doi: 10.1590/0037-8682-0251-2021. eCollection 2021.

本文引用的文献

2
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
Drug Discov Ther. 2020;14(2):100-102. doi: 10.5582/ddt.2020.03006.
3
Cyclosporine therapy during the COVID-19 pandemic.
J Am Acad Dermatol. 2020 Aug;83(2):e151-e152. doi: 10.1016/j.jaad.2020.04.153. Epub 2020 May 4.
4
Olfactory Dysfunction in COVID-19.
Otolaryngol Head Neck Surg. 2020 Jul;163(1):182. doi: 10.1177/0194599820925403. Epub 2020 May 5.
5
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.
Reumatol Clin. 2021 Nov;17(9):555-557. doi: 10.1016/j.reuma.2020.03.001. Epub 2020 Apr 16.
7
Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature.
Travel Med Infect Dis. 2020 Sep-Oct;37:101670. doi: 10.1016/j.tmaid.2020.101670. Epub 2020 Apr 14.
8
Metronidazole; a Potential Novel Addition to the COVID-19 Treatment Regimen.
Arch Acad Emerg Med. 2020 Mar 30;8(1):e40. eCollection 2020.
10
Invasion of human microvascular endothelial cells by Mycobacterium leprae through Mce1A protein.
J Dermatol. 2019 Oct;46(10):853-858. doi: 10.1111/1346-8138.15047. Epub 2019 Aug 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验